Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain.

AUTOR(ES)

Omura, S

RESUMO

Hybrid antibiotics mederrhodins A and B were produced by a recombinant strain consisting of the medermycin-producing Streptomyces sp. strain AM7161 containing part of the gene clusters for actinorhodin biosynthesis of Streptomyces coelicolor A3(2). Mederrhodin A has a hydroxyl group at the C-6 position of the medermycin molecule, and mederrhodin B is dihydromederrhodin A. The antimicrobial activity of mederrhodin A resembled that of medermycin. Mederrhodin B was almost devoid of antimicrobial activity.

Documentos Relacionados

• Production and release of polyphosphate by a genetically engineered strain of Escherichia coli.
• Sporulation and the production of antibiotics, exoenzymes, and exotonins.
• Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
• Production of a bacteriolysin by a hemolytic Escherichia coli strain.
• Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.